CJC-1295 DAC, analog GHRH the hormone release of growth hormone, opposes the MOD-GRF 1-29 by the duration of their action. This is the main difference between the two peptides.
CJC-1295 DAC has an extended duration of action, a half-life of approximately 8 daysinducing a single injection per week, before breakfast. It could be called simply CJC-1295 since, without (DACDrug Affinity Complex), MOD-GRF 1-29 is not CJC-1295 in the strict sense, but they are usually sold as distinguishing with or without CAD.
Without side effects with an appropriate assay, this peptide contributes to fat loss and muscle gain. CJC-1295 DAC could interest those wishing rarely to perform injectionswith a stable rate over time rather than intermittent dosages, that provides the maximum necessary for optimal effect.